NCT03239145 2026-03-12Pembrolizumab (Anti-PD-1) and AMG386 (Angiopoietin-2 (Ang-2) in Patients With Advanced Solid TumorDana-Farber Cancer InstitutePhase 1 Completed62 enrolled 17 charts
NCT05433142 2026-03-05Study of XmAb®819 in Subjects With Advanced Clear Cell Renal Cell CarcinomaXencor, Inc.Phase 1 Recruiting307 enrolled
NCT07072728 2026-03-03Psilocybin-Assisted Psychotherapy in Cancer Patients With Adjustment DisorderPsyence Australia Pty LtdPhase 2 Recruiting87 enrolled
NCT06546553 2026-02-23A Study to Learn About How Different Amounts of the Study Medicine PF-07826390 Act in the Body of People With Cancer When Taken Alone or With Other Anti-cancer Medicines.PfizerPhase 1 Terminated10 enrolled